1-[2-[(5-fluoro-3-pyridinyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-4-imidazol-1-ylbutan-1-one
C19H17FN6OS — CID 163614227
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-[(5-fluoro-3-pyridinyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-4-imidazol-1-ylbutan-1-one
1-[2-[(5-fluoro-3-pyridinyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-4-imidazol-1-ylbutan-1-one (PubChem CID 163614227) has the molecular formula C19H17FN6OS and a molecular weight of 396.45 g/mol. Its IUPAC name is 1-[2-[(5-fluoro-3-pyridinyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-4-imidazol-1-ylbutan-1-one.
Molecular Properties
| Compound Name | 1-[2-[(5-fluoro-3-pyridinyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-4-imidazol-1-ylbutan-1-one |
|---|---|
| PubChem CID | 163614227 |
| Molecular Formula | C19H17FN6OS |
| Molecular Weight | 396.45 g/mol |
| Exact Mass | 396.12 |
| IUPAC Name | 1-[2-[(5-fluoro-3-pyridinyl)methylamino]thieno[3,2-d]pyrimidin-4-yl]-4-imidazol-1-ylbutan-1-one |
| SMILES | O=C(CCCn1ccnc1)c1nc(NCc2cncc(F)c2)nc2ccsc12 |
| InChI | InChI=1S/C19H17FN6OS/c20-14-8-13(9-22-11-14)10-23-19-24-15-3-7-28-18(15)17(25-19)16(27)2-1-5-26-6-4-21-12-26/h3-4,6-9,11-12H,1-2,5,10H2,(H,23,24,25) |
| InChIKey | HIOWFRTXHHHQNX-UHFFFAOYSA-N |
| XLogP | 3.70 |
| TPSA | 85.59 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 396.45 |
| LogP ≤ 5 | 3.70 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163614227 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.